The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The twilight phase between being asleep and awake during recovery from anesthesia is a precarious time fraught with risks to the post-operative patient. Hyperventilation accelerates the elimination of inhaled anesthetics but reduces their CO2 blood concentrations which delays their resumption of spontaneous breathing. We previously showed that our method of hyperventilation without affecting the CO2 concentration--which we call IH--accelerates the rate of emergence from anesthesia with isoflurane. In this study we will study the effect of IH on the rate of emergence from Sevoflurane anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2005
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 18, 2005
CompletedFirst Posted
Study publicly available on registry
October 20, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedAugust 5, 2010
September 1, 2006
2.8 years
October 18, 2005
August 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to recovery from anesthesia as indicated by time to extubation and rate of change of BIS score
Secondary Outcomes (1)
Quality of recovery in the recovery room as indicated by the level of consciousness, incidence of nausea, vomiting, shivering and other phenomena occuring during recovery
Interventions
Eligibility Criteria
You may qualify if:
- Elective gynecological procedure
- ASA I-III
- Age 18-80 years
- Signed informed consent
You may not qualify if:
- ASA IV
- Patients with contra-indications to Sevoflurane anesthesia or other anesthetics included in the protocol
- Active smoking, asthma or other history of hyper-reactive airway disease
- History of chronic obstructive lung disease limiting exercise
- History of angina, previous myocardial infarction, valvular heart disease, or heart surgery
- Presence of heart murmurs or neck bruits
- ECT abnormalities including atrial fibrillation, prolonged P-R interval, prolonged Q-T interval, presence of Q waves in inferior, anterior or lateral leads, criteria for left ventricular hypertrophy, T-wave abnormalities,
- History of difficult airway access
- Pulmonary hypertension and/or right ventricle dysfunction
- History of bulous emphysema, and/or spontaneous pneumothorax
- History of alcohol or drugs abuse
- Known history of psychiatric illness and/or medications
- Patients that required postoperative mechanical ventilation for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto General Hospital, University Health Network
Toronto, Ontario, M5G 2C4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rita Katznelson, MD
Toronto General Hospital, University Health Network
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 18, 2005
First Posted
October 20, 2005
Study Start
October 1, 2005
Primary Completion
August 1, 2008
Study Completion
December 1, 2008
Last Updated
August 5, 2010
Record last verified: 2006-09